RecruitingNot applicableNCT06629636

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

Studying Female infertility due to an implantation defect of genetic origin

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sunkaky Medical Cooperation
Principal Investigator: Yoshiharu M., Yoshiharu Morimoto, MD, PhD
Sankaky Medical Corporation
Intervention: NMN capsule(dietary_supplement)
Enrollment: 60 enrolled
Eligibility: 32-42 years · FEMALE
Timeline: 2024 – 2026

Study locations (1)

IVF Namba Clinic, Sankaky Medical Corporation, Osaka, Osaka, Japan

Collaborators

Abinopharm, Inc · Aba Chemicals Co Ltd

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06629636 on ClinicalTrials.gov

← Back to all trials